Molecular screening of transitional B cells as a prognostic marker of improved graft outcome and reduced rejection risk in kidney transplant
These findings suggest that monitoring TrB may provide interesting patient management information, improve transplant outcomes, and allow for personalized drug regimens to minimize clinical complications.
Authors
- Sergio G. Garcia (ORCID: https://orcid.org/0000-0001-7698-3734)
- Laura Cañas (ORCID: https://orcid.org/0000-0002-4627-378X)
- Francesc E. Borràs (ORCID: https://orcid.org/0000-0003-4038-1912)
- Anna Vila-Santandreu
- Marcella Franquesa (ORCID: https://orcid.org/0000-0002-1287-8908)
- Miriam Font‐Morón (ORCID: https://orcid.org/0000-0002-4714-252X)
- Paula Rodríguez‐Martínez
- Inés Perezpayá
- Jordi Bover (ORCID: https://orcid.org/0000-0003-3577-2273)
- Marta Clos‐Sansalvador (ORCID: https://orcid.org/0000-0001-8522-7818)
- Marta Sanroque‐Muñoz
Institutions
- Universitat Autònoma de Barcelona (ES)
- Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (ES)
- Hospital Universitari Germans Trias i Pujol (ES)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-08-12
- DOI
- https://doi.org/10.3389/fimmu.2024.1433832
- Citations
- 3
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Agència de Gestió d'Ajuts Universitaris i de Recerca
- Instituto de Salud Carlos III
- Departament de Salut, Generalitat de Catalunya